| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/03/2008 | WO2007136671A3 Delta5 desaturase and its use in making polyunsaturated fatty acids |
| 04/03/2008 | WO2007134325A3 Methods and compositions for protein production using adenoviral vectors |
| 04/03/2008 | WO2007134272A3 Humanized models via targeted mtagenesis with zinc finger nuclease |
| 04/03/2008 | WO2007134234A3 Methods and compositions for obtaining marker-free transgenic plants |
| 04/03/2008 | WO2007130302A3 Rage fusion proteins, formulations, and methods of use thereof |
| 04/03/2008 | WO2007126799A3 Compositions and methods of use for antibodies of c-met |
| 04/03/2008 | WO2007120624A3 Concerted nucleic acid assembly reactions |
| 04/03/2008 | WO2007112051A3 Polypyrimidine-tract binding protein (ptb) as a biomarker and target for the diagnosis and treatment of cancer |
| 04/03/2008 | WO2007100789A3 Gpat3 encodes a mammalian, microsomal acyl-coa:glycerol 3-phosphate acyltransferase |
| 04/03/2008 | WO2007095201A3 Pseudotyped retroviral vectors and methods of use thereof |
| 04/03/2008 | WO2007089582A3 Lipoparticles comprising ion channels, methods of making, and using the same |
| 04/03/2008 | WO2007089161A3 DOUBLE HELICAL OLIGONUCLEOTIDES INTERFERING WITH mRNA USED AS EFFECTIVE ANTICANCER AGENT |
| 04/03/2008 | WO2007079224A3 Sirna compositions promoting scar-free wound healing of skin and methods for wound treatment |
| 04/03/2008 | WO2007028165A8 Stress tolerance in plants |
| 04/03/2008 | WO2006083971A3 Dr5 antibodies and uses thereof |
| 04/03/2008 | WO2005004794A3 Method of treating neurodegenerative disease |
| 04/03/2008 | WO2002020852A9 Amplification of hiv-1 sequences for detection of sequences associated with drug-resistance mutations |
| 04/03/2008 | US20080083045 Aromatic methyltransferases and uses thereof |
| 04/03/2008 | US20080083043 Maize Cellulose Synthases and Uses Thereof |
| 04/03/2008 | US20080081904 siRNA targeting carbonic anhydrase 4(CA4) |
| 04/03/2008 | US20080081903 Method for screening transcriptional coregulatory proteins of transcription factors, and androgen receptor transcriptional coregulatory proteins as targets for androgen receptor-dependent diseases |
| 04/03/2008 | US20080081841 Materials and Methods for Modulating Cell Motility |
| 04/03/2008 | US20080081795 Suppression of nuclear factor-kappaB dependent processes using oligonucleotides |
| 04/03/2008 | US20080081794 Smg-1 binding protein and screening method for substances that can regulate the activity thereof |
| 04/03/2008 | US20080081793 Oligonucleotide Compositions and Their Use to Induce Apoptosis |
| 04/03/2008 | US20080081792 Expression vector comprising therapeutic RNA sequences for use in treatment and prevention of infection, viral diseases and cell proliferative disorders, tumor or cancer; antisense agents; gene expression inhibition |
| 04/03/2008 | US20080081791 Methods of using combinations of siRNAs for treating a disease or a disorder, and for enhancing siRNA efficacy in RNAi |
| 04/03/2008 | US20080081373 Genetic inhibition by double-stranded RNA |
| 04/03/2008 | US20080081372 High-throughput cell transfection device and methods of using thereof |
| 04/03/2008 | US20080081366 Polynucleotide composition, method of preparation, and use thereof |
| 04/03/2008 | US20080081365 Using viral vector as tool in transduction of cells of respiratory system |
| 04/03/2008 | US20080081361 Process for production of a recombinant protein and a fusion protein |
| 04/03/2008 | US20080081359 Using yeast to form a layer of nano-gold particles on the surface of metallic silver; biofuels |
| 04/03/2008 | US20080081355 Activatable recombinant neurotoxins |
| 04/03/2008 | US20080081353 Production of recombinant human collagen |
| 04/03/2008 | US20080081352 Recombinant Microorganism |
| 04/03/2008 | US20080081337 Using beta -cell specific insulin gene transcription factor (MafA) as diagnostic tool for identifying insulin producing cells |
| 04/03/2008 | US20080081336 Variants of the Serotonin Transporter |
| 04/03/2008 | US20080081328 Modified primer for detection of DNA viruses |
| 04/03/2008 | US20080081047 severe acute respiratory syndrome; preparing a chimeric antibody; Monoclonal antibody reagents that recognize the SARS-coronavirus (SARS-HCoV) |
| 04/03/2008 | US20080081044 Compositions and methods for generation of infectious hepatitis C virus in immortalized human hepatocytes |
| 04/03/2008 | US20080081043 Nucleotide sequences coding natural killer cell ligand for use as tool in treatment cell proliferative disorders |
| 04/03/2008 | US20080081037 Methods and Agents for Diagnosis and Prevention, Amelioration or Treatment of Goblet Cell-Related Disorders |
| 04/03/2008 | DE102006046857A1 DNA sequence coding for an Aspergillus fumigatus lysophospholipase, e.g. useful for improving the filtration of sugar syrups |
| 04/03/2008 | DE102006046719A1 DNA sequence coding for an Aspergillus fumigatus phospholipase, e.g. useful for desliming vegetable oil |
| 04/03/2008 | DE102006046423A1 Nucleic acid molecule useful for characterizing antiretroviral agents comprises a coding sequence for an HIV mutant capable of replication in vitro and a coding sequence for a luciferase |
| 04/03/2008 | DE102006044841A1 Signalpeptid zur Produktion von rekombinanten Proteinen Signal peptide for the production of recombinant proteins |
| 04/03/2008 | CA2667756A1 Blocking of gene expression in eukaryotic cells |
| 04/03/2008 | CA2667396A1 Transcriptional repressors of cytokinin signaling and their use |
| 04/03/2008 | CA2664921A1 N-terminal fgf variants having increased receptor selectivity and uses thereof |
| 04/03/2008 | CA2664767A1 Galactosyltransferase |
| 04/03/2008 | CA2664752A1 Antibodies against ccr5 and uses thereof |
| 04/03/2008 | CA2664546A1 The maize erecta genes for improving plant growth, transpiration efficiency and drought tolerance in crop plants |
| 04/03/2008 | CA2664498A1 Plant cell lines established from the medicinal plant veratrum californicum |
| 04/03/2008 | CA2664414A1 Methods and means for removal of a selected dna sequence |
| 04/03/2008 | CA2664363A1 Rapid in vivo model for angiogenesis |
| 04/03/2008 | CA2664211A1 Nucleic acid purification method |
| 04/03/2008 | CA2664156A1 Compositions of tlr ligands and antivirals |
| 04/03/2008 | CA2663711A1 Acetolactate synthase (als) selectable marker from trichoderma reesei |
| 04/03/2008 | CA2663026A1 Apoptotic cell-mediated transfection of mammalian cells with interfering rna |
| 04/03/2008 | CA2654174A1 Rna nanoparticles and nanotubes |
| 04/02/2008 | EP1906184A1 Diagnostic agent and therapeutic agent for disease related to macrocyte and macrophage |
| 04/02/2008 | EP1905845A2 Method for detecting multiple myeloma and method for inhibiting the same |
| 04/02/2008 | EP1905837A1 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 04/02/2008 | EP1905836A1 Recombinant Pichia pastoris strains and process for the production of recombinant human interferon alpha |
| 04/02/2008 | EP1905835A1 Signal peptide for the production of recombinant proteins |
| 04/02/2008 | EP1905834A2 Virulence Genes, Proteins, and their Use |
| 04/02/2008 | EP1905833A2 Polypeptides involved in the biosynthesis of spiramycins, nucleotide sequences coding these polypeptides and their uses |
| 04/02/2008 | EP1905832A2 Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 04/02/2008 | EP1905831A2 Lactoferrin receptor genes of moraxella |
| 04/02/2008 | EP1905830A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/02/2008 | EP1905829A2 Templated molecules and methods for using such molecules |
| 04/02/2008 | EP1905828A2 Optical sorting method |
| 04/02/2008 | EP1905827A1 A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator |
| 04/02/2008 | EP1905826A1 Galactosyltransferase |
| 04/02/2008 | EP1905825A1 Galactosyltransferase |
| 04/02/2008 | EP1905824A1 A transgenic cell and a method for cell analysis |
| 04/02/2008 | EP1905822A2 Discharge volume control method and injecting apparatus |
| 04/02/2008 | EP1905782A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 04/02/2008 | EP1905780A1 Cancer suppressing agent |
| 04/02/2008 | EP1905449A2 Vaccines |
| 04/02/2008 | EP1905304A2 Treatment of neoplasms with viruses |
| 04/02/2008 | EP1904849A2 Anti fungal screening method |
| 04/02/2008 | EP1904643A2 Production of cpd glycosylases |
| 04/02/2008 | EP1904639A2 Dehydrin genes and promoters from coffee |
| 04/02/2008 | EP1904638A2 Mucosal or enteral administration of biologically active macromolecules |
| 04/02/2008 | EP1904637A2 Transformed plants accumulating mono- and/or sesquiterpenes |
| 04/02/2008 | EP1904636A2 Improvements in or relating to protein production |
| 04/02/2008 | EP1904635A2 Glycosylated il-7, preparation and uses |
| 04/02/2008 | EP1904634A2 Novel phage display technologies |
| 04/02/2008 | EP1904633A1 Method for the purification of dna/rna of proteins and cellular residual substances in cell lysate |
| 04/02/2008 | EP1904632A1 A microorganism of enterobacteriacae genus haboring genes associated with l-carintine biosynthesis and methos of producing l-carnitine using the microorganism |
| 04/02/2008 | EP1904631A2 Prrs viruses, infectious clones, mutants thereof, and methods of use |
| 04/02/2008 | EP1904630A1 Methods of treatment, and diagnosis of epilepsy by detecting mutations in the scn1a gene |
| 04/02/2008 | EP1904626A1 Chimeric empty viral-like particles derived from the infectious bursal disease virus (ibdv), process for their production and applications |
| 04/02/2008 | EP1904622A2 Constitutive promoters from poplar and uses thereof |
| 04/02/2008 | EP1904529A2 Scaffold |
| 04/02/2008 | EP1904528A1 Host cell protein knock-out cells for production of therapeutic proteins |
| 04/02/2008 | EP1904523A1 Defensin proteins |
| 04/02/2008 | EP1904521A2 Novel bacterial proteins with pesticidal activity |